IMCD Buys Brazil’s VitaQualy
“The acquisition of VitaQualy aligns with our company’s global food & nutrition strategy to offer trend-based solutions and the distribution of specialty ingredients around four main pillars – taste, texture, nutrition and function,” said Nicolas Kaufmann, managing director/Brazil at IMCD. “The synergies between IMCD and VitaQualy will create opportunities to develop our offering to suppliers and customers, while further strengthening our foothold as a specialty distribution leader in Brazil.”
VitaQualy generated revenues of 26 million Brazilian reals in 2019 and adds eight employees to IMCD’s Brazilian team.
-
IMCD has acquired VitaQualy Comercio de Ingredientes, a supplier of specialty ingredients for Brazil’s food, nutrition, pharmaceutical and nutraceutical markets. VitaQualy had revenues of 26 million Brazilian reals in 2019 and adds eight employees to IMCD’s Brazilian team. (c) IMCD
Acquisitions boost H1 profits
IMCD has posted a 7% rise in operating EBITA for the first half of 2020, reaching €131.4 million, the combined result of organic growth and the first-time inclusion of acquisitions that closed in 2019 and 2020. Revenues edged up 1% to just above €1.4 billion.
“Although the market circumstances due to the Covid-19 crisis were challenging, in Q2 we were able to improve our operating EBITA by 4% due to a strong performance in the Americas and Asia-Pacific,” said IMCD’s CEO, Piet van der Slikke.
Operating EBITA in the Americas was 13% higher year on year at €47.6 million while in Asia-Pacific it jumped 26% to €21.9 million.
On Jul. 13, IMCD bought the pharmaceutical business of China’s Develing International Trade (Shanghai). Develing, with a regional head office in Shanghai, is a Dutch distributor of ingredients for the food, pharmaceutical, chemical and feed industries in China and Vietnam with annual sales of about €10 million.
Author: Elaine Burridge, Freelance Journalist
